biocryst nasdaq realtime

BioCryst Pharmaceuticals (NASDAQ:BCRX) last posted its quarterly earnings results on Wednesday, February 24th. $12.68. BNK Invest caters to investing firms and individual investors internationally. Real-time exchange rate quote of BioCryst Pharmaceuticals, Inc. including detailed information, live chart and news, profile and other market data. These symbols will be available throughout the site during your session. The currently approved medication for BioCryst is peramivir, which we will discuss further in this piece. Check the real-time BCRX stock price on the NASDAQ exchange and access historical data for BioCryst Pharmaceuticals, Inc. stock. Data is currently not available. Real time BioCryst Pharmaceuticals (BCRX) stock price quote, stock graph, news & analysis. Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB. Latest Share Price and Events Stable Share Price : BCRX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 16% a week. RBLX Stock Price: How High Will Roblox Stock Go? Approximately 6,345,274 shares changed hands during mid-day trading, a decline of 11% from the average daily volume of 7,123,782 shares. Investors in BioCryst Pharmaceuticals Inc (Symbol: BCRX) saw new options become available this week, for the May 21st expiration. The largest stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) was held by Baker Bros. Advisors, which reported holding $21.9 million worth … BCRX | Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. Investors in BioCryst Pharmaceuticals Inc (Symbol: BCRX) saw new options become available this week, for the May 21st expiration. To short BioCryst Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. BioCryst Pharmaceuticals Aktie und BCRX Kursdiagramme. The options have an exercise price of $7.45 per share, which is equal to the closing price of BioCryst common stock on the grant date. The Top 25 Broker Analyst Picks of the S&P 500 ». The brokerage presently has an "overweight" rating on the biotechnology company's stock. Das Volumen addierte 8, 414, 830 Aktien, die mit dem durchschnittlichen Volumen von 8 verglichen werden. Copy and paste multiple symbols separated by spaces. Instantly find out the BioCryst Pharmaceuticals, Inc. stock quote Data is currently not available. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Auf – – 2020 (Montag) Aktien von BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) ergab einen Unterschied von 8. BCRX | Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. BioCryst Pharmaceuticals Inc: BCRX: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -0.67-4.97%: 12.81: 15:18:33: Open Price Low Price High Price Close Price Prev Close; 13.50: 12.63: 13.75: 13.48: Support 1 Support 2 Pivot Price Resistance 1 Resistance 2; 12.3767 : 11.9433 : 13.0633 : 13.4967 : 14.1833 : more quote information » BCRX Chart. Kostenlose Echtzeit-Kurse und aktive Aktienmarkt-Foren. -0.055 (-0.49%) CLOSED AT 4:00 PM ET ON Mar 08, 2021. BioCryst Pharmaceuticals (NASDAQ:BCRX) last released its quarterly earnings data on Wednesday, February 24th. The MarketWatch News Department was not involved in the creation of this content. But the whole reason to look at the average BCRX price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. Click here now. (NASDAQ: BCRX) Biocryst Pharmaceuticals currently has 176,565,622 outstanding shares. What Is BioCryst Pharmaceuticals's Net Debt? VAT not included. A number of brokerages have recently issued … BidaskClub upgraded shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) from a sell rating to a hold rating in a report issued on Wednesday morning, BidAskClub reports. ATX 3 158 0,3% DAX 14 502 -0,5% Dow 32 779 0,9% EStoxx50 3 833 -0,3% Nasdaq 12 937 -0,9% Öl 69,2 -0,6% Euro 1,1954 -0,3% CHF 1,1109 0,3% Gold 1 727 0,2% Data is currently not available. Monthly Subscription. Ausführliches Aktienporträt der BioCryst Pharmaceuticals - WKN 896047, ISIN US09058V1035 - bei finanztreff.de topaktuell! BioCryst Pharmaceuticals Inc: BCRX: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -0.23-1.77%: 12.76: 00:00:07: Open Price Low Price High Price Close Price Prev Close; 12.87: 12.30: 13.16: 12.64: 12.99: more quote information » Recent News. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014. In recent trading, shares of BioCryst Pharmaceuticals Inc (Symbol: BCRX) have crossed above the average analyst 12-month target price of $11.78, changing hands for $12.07/share. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) was in 26 hedge funds' portfolios at the end of June. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. Create your Watchlist to save your favorite quotes on Nasdaq.com. The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.25) by ($0.09). In recent trading, shares of BioCryst Pharmaceuticals Inc (Symbol: BCRX) have crossed above the average analyst 12-month target price of $11.78, changing hands for … $11.095. Recently, BioCryst … BioCryst Pharmaceuticals, Inc. Common Stock, Do Not Sell My Personal Information (CA Residents Only). The standard deviation is $3.153. BioCryst Aktie (BCRX) mit Realtime-Aktienkurs, Chart, Bilanzinformationen, Dividenden, historischen Daten, aktuellen News und Analysen. $67.09. 54 – 4 am Dienstag, November 10 hinzugefügt 4. % danach wurde die Tagessitzung bei $ 4 geschlossen. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Create your Watchlist to save your favorite quotes on Nasdaq.com. BioCryst to Host Virtual R&D Day on March 22, 2021. Get the latest BioCryst Pharmaceuticals, Inc. (BCRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Kursdaten & Kursvergleich der BioCryst Pharmaceuticals - WKN 896047, ISIN US09058V1035 - bei finanztreff.de kostenlos, realtime oder verzögert. lll BioCryst Pharmaceuticals PUSH-Chart | Push-Chartanalysen aktuelle Performance jetzt in Realtime einfach und schnell bei ariva.de ansehen. Type a symbol or company name. The stock had previously closed at $11.10. Nasdaq 100. If you had invested in Biocryst Pharmaceuticals stock at … BioCryst Pharmaceuticals has a 52 week low of $1.58 and a 52 week high of $12.90. Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) rose 8.7% during mid-day trading on Tuesday . for only. View real-time stock prices and stock quotes for a full financial overview. Below is a table showing the current thinking of the analysts that cover BioCryst Pharmaceuticals Inc: The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. The all time high for this statistics is 25. 80 M Aktien. This article used data provided by Zacks Investment Research via Quandl.com. Free forex prices, toplists, indices and lots more. These symbols will be available throughout the site during your session. lll BioCryst Pharmaceuticals Chart Chartanalysen aktuelle Performance jetzt in Realtime einfach und schnell bei ariva.de ansehen. Biocryst Pharmaceuticals Aktie (BCRX) Branche: : (WKN: 896047 ISIN: US09058V1035 ) Kurs mit Realtime Chart Alle Entwicklungen, Kommentare und News auf BörsenNEWS.de live verfolgen. As you can see below, BioCryst Pharmaceuticals had US$80.6m of debt, at June 2020, which is about the same as the year before. $11.095. Results are available at a quick glance. Free forex prices, toplists, indices and lots more. What Stifel Thinks, Cardano News: Coinbase Pro Adding ADA, 9 Things to Know Before Trading Begins March 18, The Week's Top Stories: Fed Effect, AstraZeneca, and March Madness, Professional Cornhole Makes Its Sports Betting Debut on DraftKings, SAFE Banking Act for Cannabis Industry Reintroduced in House, Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys, Lit Markets Provide Price Improvement Too, data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on BCRX — FREE, Top 25 Broker Analyst Picks of the S&P 500, Analyst target price data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on BCRX - FREE, Do Not Sell My Personal Information (CA Residents Only). Aktuelle Aktienkurse der BIOCRYST PHARMACEUTICALS INC, Börsenkurs 10,66 -6,61 %, Tief 10,660, Hoch 12,025 When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. BioCryst Pharmaceuticals Inc. Aktie aktuelle News Realtime Kurs & Chart Fundamentaldaten, Analysen & mehr - BioCryst Pharmaceuticals Inc. Aktie 896047, US09058V1035 Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher — if things are looking up for the company, perhaps it is time for that target price to be raised. Nasdaq 100. Nasdaq 100. The summary for BIOCRYST PHARMACEUTICALS INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) Nasdaq Listed. The biotechnology company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.09). When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. Type a symbol or company name. The company traded as high as $12.31 and last traded at $12.07. 14/03/2021 04:07:02 1 … $11.11. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares, dropped in value on Thursday, Feb 04, with the stock price down by -6.31% to the previous day’s close as weak demand from buyers trailed the stock to $9.65. stock was originally listed at a price of $7.00 in Dec 31, 1997. BioCryst to Host Virtual R&D Day on March 22, 2021. BioCryst Pharmaceuticals Aktie: Hier finden Sie den BioCryst Pharmaceuticals Aktienkurs aktuell und ausserdem weitere Informationen wie den BioCryst Pharmaceuticals Chart View real-time stock prices and stock quotes for a full financial overview. The two main areas that BioCrysts works in are the anti-viral space and the complement space. There are analysts with lower targets than the average, including one looking for a price of $7.00. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Get BioCryst Pharmaceuticals Inc (BCRX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. BioCryst Pharmaceuticals Aktie - Hier finden Sie: BioCryst Pharmaceuticals Aktienkurs aktuell, Kurs, Chart und alle Kennzahlen für die BioCryst Pharmaceuticals Aktie. BioCryst to Host Virtual R&D Day on March 22, 2021 March 11, 2021 Early Access to BioCryst’s Berotralstat Granted for HAE Patients in France March 2, 2021 BioCryst Submits Marketing Authorization Application for UK Approval of ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema And then on the other side of the spectrum one analyst has a target as high as $16.00. BioCryst Pharmaceuticals had a negative net margin of 233.45% and a negative return on equity of 328.70%. It has also been approved in Japan, Korea and China The company was founded in 1986 by Charles E. Bugg, Ph.D. and John A. Montgomery, Ph.D. -0.31 (-2.39%) DATA AS OF Mar 12, 2021 12:00 PM ET. Best Crypto Stocks To Buy Right Now As Bitcoin (BTC) Breached $60K? JPMorgan Chase & Co.'s price objective indicates a potential upside of 18.20% from the stock's current price. BioCryst Pharmaceuticals (BCRX) share price, charts, trades & the UK's most popular discussion forums. At Stock Options Channel, our … The biotechnology company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.09). RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will host a … %, der Ausblick über die letzten fünf Tage waren rot. BioCryst Pharmaceuticals, Inc. Common Stock. Call Option for BioCryst Pharmaceuticals Inc. BCRX#A1521E800000. 26. 11/03/2021 00:22:52 1 … BioCryst Pharmaceuticals' stock is trading down $0.47 today. Get the hottest stocks to trade every day before the market opens 100% free. Needham & Company LLC reaffirmed a hold rating on shares of BioCryst Pharmaceuticals in a research report on Wednesday, November 6th. Source: NASDAQ Stocks, Symbol: BioCryst Pharmaceuticals, Inc. 26-20:27 GMT. Copy and paste multiple symbols separated by spaces. Biocryst Pharmaceuticals. $11.40. Short sellers are betting that BioCryst Pharmaceuticals will decline in price. Stay up to date with the latest discoveries, events, and reports from BioCryst. A number of other equities analysts also recently weighed in on the company. BioCryst Pharmaceuticals, WKN: 896047, ISIN: US09058V1035 Aktueller Aktienkurs, Charts, News, Stammdaten anzeigen Type a symbol or company name. © 2021, Nasdaq, Inc. All Rights Reserved. There are 9 different analyst targets contributing to that average for BioCryst Pharmaceuticals Inc, but the average is just that — a mathematical average. BioCryst Pharmaceuticals had a negative net margin of 233.45% and a negative return on equity of 328.70%. Free trial. The all time high for this statistics is 25. -0.055 (-0.49%) CLOSED AT 4:00 PM ET ON Mar 08, 2021. Technical analysis gauges display real-time ratings for the selected timeframes. BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target raised by stock analysts at JPMorgan Chase & Co. from $10.00 to $15.00 in a report issued on Wednesday, The Fly reports. Realtime-Chart und Realtime-Kurs für die BioCryst Pharmaceuticals Aktie auf BÖRSE ONLINE. 58% zum Tageskurs der Aktie. With Biocryst Pharmaceuticals stock trading at $12.64 per share, the total value of Biocryst Pharmaceuticals stock (market capitalization) is $2.23B. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4). Handelsinformationen von BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) BCRX ist sofort grün, wie dies heute im Intraday-Handel mit Aktion 1 zu sehen ist. Hinweis. Type a symbol or company name. BioCryst (NASDAQ:BCRX) develops novel, oral and small molecules that inhibit enzymes playing a key role in biological pathways of rare diseases. Free forex prices, toplists, indices and lots more. Touch device users, explore by touch or with swipe gestures. BioCryst Pharmaceuticals (BCRX) stock price, charts, trades & the US's most popular discussion forums. © 2021, Nasdaq, Inc. All Rights Reserved. How has BioCryst Pharmaceuticals's share price performed over time and what events caused price changes? You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. BioCryst Pharmaceuticals Reaches Analyst Target Price, Didn't Get Your Second Stimulus Check? RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today … RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today … Auf dieser Seite erhalten Sie Realtimekurse für Nasdaq 100 -Werte (Bid/Ask) in Dollar (Bats Realtime Indikation). BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today the pricing of an underwritten public offering of 18,711,113 shares of its common stock, offered at a price to the public of $4.50 per share. BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) Nasdaq Listed. The program will cover BioCryst’s unique, proven and prolific approach to developing oral medicines for rare diseases, with a focus on BCX9930, an oral … BIOCRYST PHARM (896047 | US09058V1035): Alle Börsen- und Handelsplätze mit aktuellen Kursen im Überblick. (BCRX) Nasdaq Listed. Free forex prices, toplists, indices and lots more. When autocomplete results are available use up and down arrows to review and enter to select. Get the latest Zacks research report on BCRX — FREE. RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will host a virtual R&D day on Monday, March 22, 2021 from 9:00 am to 11:00 am ET. And so with BCRX crossing above that average target price of $11.78/share, investors in BCRX have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $11.78 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Here's What to Do. BioCryst Pharmaceuticals (NASDAQ: BCRX) is a mid-cap biotechnology company that is developing medications on two main areas of focus, and has one commercialized medications. Add to Watchlist. Der Sprung zu wöchentlichen Höchstständen von 4 US-Dollar. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. BNK Invest Inc. provides investment services and information. BioCryst Pharmaceuticals (BCRX) stock price, charts, trades & the US's most popular discussion forums. BioCryst Pharmaceuticals (BCRX) stock price, charts, trades & the US's most popular discussion forums. At Stock Options Channel, our … BioCryst Pharmaceuticals (NASDAQ:BCRX) last posted its quarterly earnings results on Wednesday, February 24th.
biocryst nasdaq realtime 2021